Miracle drugs are not always found in a high-profile, securely guarded research facility. Some can be found in a good old-fashioned drug store. Ibuprofen, studies imply, can decrease developing risks of Parkinson's, a disease that can often cause tremors and impaired movement from a lack of dopamine in the brain. Scientists previously believed that non-steroidal anti-inflammatory drugs might shield against the disease, but many were unsure which one would prove most effective. Of the many NSAIDs tested, such as aspirin and acetaminophen, people who used ibuprofen two to three times weekly reduced the risk of Parkinson's by 38 percent.
The article published online in "Neurology" holds captivating implications for the lives of more than one million Americans suffering from the disease. It is unclear how the drug affects the death of nerve cells or the onset of Parkinson's disease, but some scientists believe it targets the peroxisome proliferator-activated receptor y, which affects the transcription and expression of genes.\nEven though scientists have discovered this added benefit of ibuprofen, a drug which also treats arthritis, they are still unsure whether the benefits outweigh the costs. Like all NSAIDs, ibuprofen has an increased risk of side effects, including stomach pains, gastrointestinal bleeding and comas. A small increased risk of heart attack is also reported.
-compiled by Fiza Hashmi
Read More
U.Va. students and physicians team up for another year of free kidney screenings
By Merrill Hart | November 5, 2024Saturday’s screening marked the first by KDSAP at Portico Church, near IX Art Park.
U.Va. Health sees a spike in COVID-19 cases
By Emily Horn | September 4, 2023U.Va. Health ended their vaccination requirements in August, and masks were made optional in most hospital areas in early April.
U.Va. Cancer Center harnesses $12 million grant to support opportunities for undergraduates, ongoing research and new center
By Ellen Wu | January 12, 2023The grant provides an opportunity to establish the Center for Systems Analysis of Stress-Adapted Cancer Organelles, which seeks to find the cause of cancer in individual organelles.
